Literature DB >> 15870264

Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages.

Philipp Oberdoerffer1, Chryssa Kanellopoulou, Vigo Heissmeyer, Corinna Paeper, Christine Borowski, Iannis Aifantis, Anjana Rao, Klaus Rajewsky.   

Abstract

RNA interference (RNAi) is a naturally occurring posttranscriptional gene-silencing mechanism that has been adapted as a genetic tool for loss-of-function studies of a variety of organisms. It is more widely applicable than classical gene targeting and allows for the simultaneous inactivation of several homologous genes with a single transgene. Recently, RNAi has been used for conditional and conventional gene inactivation in mice. Unlike gene targeting, RNAi is a dynamic process, and its efficiency may vary both between cell types and throughout development. Here we demonstrate that RNAi can be used to target three separately encoded isoforms of the bcl-2 family gene bfl-1/A1 in a conditional manner in mice. The extent of gene inactivation varies between different cell types and is least efficient in mature lymphocytes. Our data suggest that RNAi is affected by factors beyond small interfering RNA-mRNA stoichiometry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870264      PMCID: PMC1087705          DOI: 10.1128/MCB.25.10.3896-3905.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

2.  RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.

Authors:  P D Zamore; T Tuschl; P A Sharp; D P Bartel
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

3.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

Authors:  R J Grumont; I J Rourke; S Gerondakis
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Mcl-1 deficiency results in peri-implantation embryonic lethality.

Authors:  J L Rinkenberger; S Horning; B Klocke; K Roth; S J Korsmeyer
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

6.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

7.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

8.  Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein.

Authors:  S K Jang; E Wimmer
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

9.  Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice.

Authors:  N Motoyama; F Wang; K A Roth; H Sawa; K Nakayama; K Nakayama; I Negishi; S Senju; Q Zhang; S Fujii
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

10.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2.

Authors:  E Y Lin; A Orlofsky; M S Berger; M B Prystowsky
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

View more
  32 in total

Review 1.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  Double-stranded Let-7 mimics, potential candidates for cancer gene therapy.

Authors:  Qi-zhao Wang; Ying-hui Lv; Yu-hua Gong; Zhao-fa Li; William Xu; Yong Diao; Ruian Xu
Journal:  J Physiol Biochem       Date:  2011-11-09       Impact factor: 4.158

Review 3.  Transgenic RNAi: Accelerating and expanding reverse genetics in mammals.

Authors:  Xu-Gang Xia; Hongxia Zhou; Zuoshang Xu
Journal:  Transgenic Res       Date:  2006-06       Impact factor: 2.788

Review 4.  Artificial chromosome-based transgenes in the study of genome function.

Authors:  Jason D Heaney; Sarah K Bronson
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

5.  Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid.

Authors:  Malay Mandal; Kelly M Crusio; Fanyong Meng; Suqing Liu; Marcus Kinsella; Marcus R Clark; Osamu Takeuchi; Iannis Aifantis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

Review 6.  In vivo RNAi screens: concepts and applications.

Authors:  Shane Crotty; Matthew E Pipkin
Journal:  Trends Immunol       Date:  2015-04-27       Impact factor: 16.687

Review 7.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

8.  Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation.

Authors:  Andrea C Eitelhuber; Sebastian Warth; Gisela Schimmack; Michael Düwel; Kamyar Hadian; Katrin Demski; Wolfgang Beisker; Hisaaki Shinohara; Tomohiro Kurosaki; Vigo Heissmeyer; Daniel Krappmann
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

9.  Efficient inhibition of human cytomegalovirus DNA polymerase expression by small hairpin RNA in vitro.

Authors:  Ran Tao; Miaofeng Hu; Qunjun Duan; Shiqiang Shang
Journal:  Curr Microbiol       Date:  2008-08-05       Impact factor: 2.188

10.  Prnp knockdown in transgenic mice using RNA interference.

Authors:  Micaela Gallozzi; Jérome Chapuis; Fabienne Le Provost; Annick Le Dur; Caroline Morgenthaler; Coralie Peyre; Nathalie Daniel-Carlier; Eric Pailhoux; Marthe Vilotte; Bruno Passet; Laetitia Herzog; Vincent Beringue; José Costa; Philippe Tixador; Gaëlle Tilly; Hubert Laude; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2008-03-19       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.